Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters

International Immunopharmacology

Volumn 8, Issue 1, 2008, Pages 20-27

  Karlsson, Agneta ^a   Jägervall, Åke ^a   Pettersson, Madeleine ^a   Andersson, Ann Katrin ^a   Gillberg, Per Göran ^a   Melgar, Silvia ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

DSS; Hamster; Hepatic function; Inflammatory bowel disease; Lipoprotein lipase; Triglycerides

Indexed keywords

ACYL COENZYME A OXIDASE; BIOLOGICAL MARKER; CYTOCHROME P450; DEXTRAN; DEXTRAN SULPHATE SODIUM; DRINKING WATER; FATTY ACID; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CLINICAL FEATURE; COLITIS; COLON; COLON WEIGHT; CONTROLLED STUDY; EPITHELIUM CELL; HAMSTER; INFLAMMATION; INFLAMMATORY CELL; LIVER; LIVER FUNCTION; LIVER WEIGHT; MALE; NONHUMAN; ORGAN WEIGHT; PLASMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRIACYLGLYCEROL BLOOD LEVEL; WASTING SYNDROME;

ACUTE DISEASE; ANIMALS; COLITIS; CRICETINAE; DEXTRAN SULFATE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION MEDIATORS; INFLAMMATORY BOWEL DISEASES; LIVER; LIVER FUNCTION TESTS; MALE; MESOCRICETUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PILOT PROJECTS;

EID: 36749014665     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2007.10.007     Document Type: Article

References (31)

1. Podolsky D.K. Inflammatory bowel disease. [see comment]. N Engl J Med 347 (2002) 417-429
2. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
3. Melgar S., Karlsson A., and Michaelsson E. Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gasterointest Liver Physiol 288 (2005) G1328-G1338
4. Ni J., Chen S.F., and Hollander D. Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. Gut 39 (1996) 234-241
5. Mahler M., Bristol I.J., Leiter E.H., Workman A.E., Birkenmeier E.H., Elson C.O., et al. Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274 (1998) G544-G551
6. Adams D.H., and Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol 6 (2006) 244
7. Hardardottir I., Grunfeld C., and Feingold K.R. Effects of endotoxin on lipid metabolism. Biochem Soc Trans 23 (1995) 1013-1018
8. Khovidhunkit W., Kim M.S., Memon R.A., Shigenaga J.K., Moser A.H., Feingold K.R., et al. Thematic review series: the pathogenesis of atherosclerosis. Effects of infection and inflammation on lipid and lipoprotein metabolism mechanisms and consequences to the host. J Lipid Res 45 (2004) 1169-1196
9. Larsson A.E., Melgar S., Rehnstrom E., Michaelsson E., Svensson L., Hockings P., et al. Magnetic resonance imaging of experimental mouse colitis and association with inflammatory activity. Inflamm Bowel Dis 12 (2006) 478-485
10. Melgar S., Bjursell M., Gerdin A.K., Svensson L., Michaelsson E., and Bohlooly Y.M. Mice with experimental colitis show an altered metabolism with decreased metabolic rate. Am J Physiol Gasterointest Liver Physiol 292 (2007) G165-G172
11. Jurjus A.R., Khoury N.N., and Reimund J.M. Animal models of inflammatory bowel disease. J Pharmacol Toxicol Methods 50 (2004) 81-92
12. Byrne F.R., and Viney J.L. Mouse models of inflammatory bowel disease. Curr Opin Drug Disc Dev 9 (2006) 207-217
13. Sasaki S., Hirata I., Maemura K., Hamamoto N., Murano M., Toshina K., et al. Prostaglandin E2 inhibits lesion formation in dextran sodium sulphate-induced colitis in rats and reduces the levels of mucosal inflammatory cytokines. Scand J Immunol 51 (2000) 23-28
14. Don B.R., and Kaysen G. Serum albumin: relationship to inflammation and nutrition. Sem Dial 17 (2004) 432-437
15. Wang Y., Kinzie E., Berger F.G., Lim S.K., and Baumann H. Haptoglobin, an inflammation-inducible plasma protein. Redox Report 6 (2001) 379-385
16. Masubuchi Y., and Horie T. Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis. Drug Metab Dispos 32 (2004) 437-441
17. Scott J.R., and Fox-Robichau A.E. Hepatic leukocyte recruitment in a model of acute colitis. Am J Physiol Gastrointest Liver Physiol 283 (2002) G561-G656
18. Heimerl S., Moehle C., Zahn A., Boettcher A., Stremmel W., Langmann T., et al. Alterations in intestinal fatty acid metabolism in inflammatory bowel disease. Biochim Biophys Acta Mol Basis Dis 1762 (2006) 341
19. Peyrin-Biroulet L., Chamaillard M., Gonzalez F., Beclin E., Decourcelle C., Antunes L., et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander?. Gut 56 (2007) 577-583
20. Singh I., Paintlia A.S., Khan M., Stanislaus R., Paintlia M.K., Haq E., et al. Impaired peroxisomal function in the central nervous system with inflammatory disease of experimental autoimmune encephalomyelitis animals and protection by lovastatin treatment. Brain Res 1022 (2004) 1-11
21. Warren G.W., Van Ess P.J., Watson A.M., Mattson M.P., and Blouin R.A. Cytochrome P450 and antioxidant activity in interleukin-6 knockout mice after induction of the acute-phase response. J Interferon Cytokine Res 21 (2001) 821-826
22. Rip J., Nierman M.C., Ross C.J., Jukema J.W., Hayden M.R., Kastelein J.J.P., et al. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol 26 (2006) 1236-1245
23. Feingold K.R., Hardardottir I., Memon R., Krul E.J.T., Moser A.H., Taylor J.M., et al. Effect of endotoxin on cholesterol biosynthesis and distribution in serum lipoproteins in Syrian hamsters. J Lipid Res 34 (1993) 2147-2158
24. Levy E., Rizwan Y., Thibault L., Lepage G., Brunet S., Bouthillier L., et al. Altered lipid profile, lipoprotein composition, and oxidant and antioxidant status in pediatric Crohn disease. Am J Clin Nutr 71 (2000) 807-815
25. Kosaka T., Yoshino J., Inui K., Wakabayashi T., Okushima K., Kobayashi T., et al. Impact of lipoprotein lipase gene polymorphisms on ulcerative colitis. World J Gastroenterol 12 (2006) 6325-6330
26. Sullivan M.P., Cerda J.J., Robbins F.L., Burgin C.W., and Beatty R.J. The gerbil, hamster, and guinea pig as rodent models for hyperlipidemia. Lab Anim Sci 43 (1993) 575-578
27. Shiota N., Fukamizu A., Takai S., Okunishi H., Murakami K., and Miyazaki M. Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart. J Hypertens 15 (1997) 431-440
28. Schulz H., Mohr M., and Meyer M. Elastase and papain inhibition by serum of mammals. Scand J Clin Lab Invest 49 (1989) 381-388
29. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., and Elson C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107 (1994) 1643-1652
30. Guo Q., Sahoo S.P., Wang P.R., Milot D.P., Ippolito M.C., Wu M.S., et al. A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist demonstrates favorable effects on lipid homeostasis. Endocrinology 145 (2004) 1640-1648
31. Domenech V.S., Nylen E.S., White J.C., Snider Jr. R.H., Becker K.L., Landmann R., et al. Calcitonin gene-related peptide expression in sepsis: postulation of microbial infection-specific response elements within the calcitonin I gene promoter. J Investig Med 49 (2001) 514-521